Reuters logo
BRIEF-Mylan receives marketing authorization approval in Europe for first generic for Copaxone 40 mg/ml
October 5, 2017 / 5:32 PM / 2 months ago

BRIEF-Mylan receives marketing authorization approval in Europe for first generic for Copaxone 40 mg/ml

Oct 5 (Reuters) - Mylan NV :

* Mylan, in partnership with Synthon, receives marketing authorization approval in Europe for first generic for Copaxone 40 mg/ml

* Granting of national marketing authorizations for Glatiramer Acetate injection is expected to follow in near future Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below